The recent drop in prices must have disappointed Inhibrx Biosciences, Inc....

Published on 17 Nov 2024 on Simply Wall St. · via Yahoo Finance

Key Insights Given the large stake in the stock by institutions, Inhibrx Biosciences' stock price...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights Given the large stake in the stock by institutions, Inhibrx Biosciences' stock price...

Simply Wall St. · via Yahoo Finance 17 Nov 2024

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.73 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 28 Feb 2024

Following a hot year of M&A with biotech stocks, we’ll see more of the same in 2024 as drug maker...

InvestorPlace via Yahoo Finance 15 Feb 2024

Merger updates and other regulatory news were in focus in the biotech sector ahead of the fourth-...

Zacks via Yahoo Finance 28 Jan 2024

Inhibrx INBX and Sanofi SNY announced a definitive agreement wherein the latter will acquire the ...

Zacks via Yahoo Finance 21 Jan 2024

Inhibrx, Inc. INBX shares ended the last trading session 8.9% higher at $36.30. The jump came on ...

Zacks via Yahoo Finance 21 Jan 2024

In this piece, we will take a look at the 12 best high risk high reward stocks to buy now. If you...

Insider Monkey via Yahoo Finance 1 Sep 2023

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Investing.com 29 Aug 2023

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarte...

Insider Monkey via Yahoo Finance 19 May 2023

Inhibrx, Inc. (INBX) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus...

Zacks via Yahoo Finance 8 May 2023